Publicaciones (108) Publicaciones de María Ángeles Almeida Parra

2024

  1. A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  2. Pursuing precision in medicine and nutrition: the rise of electrochemical biosensing at the molecular level

    Analytical and Bioanalytical Chemistry, Vol. 416, Núm. 9, pp. 2151-2172

2023

  1. Brightness and shadows of mitochondrial ROS in the brain

    Neurobiology of Disease, Vol. 184

  2. Cross-talk between energy and redox metabolism in astrocyte-neuron functional cooperation

    Essays in biochemistry, Vol. 67, Núm. 1, pp. 17-26

  3. Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition

    Nature Metabolism, Vol. 5, Núm. 8, pp. 1290-1302

  4. Mitochondrial sodium/calcium exchanger NCLX regulates glycolysis in astrocytes, impacting on cognitive performance

    Journal of Neurochemistry, Vol. 165, Núm. 4, pp. 521-535

2022

  1. APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer’s disease

    Frontiers in Pharmacology

  2. Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis

    Nature Communications, Vol. 13, Núm. 1

  3. Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration

    Frontiers in Pharmacology, Vol. 13

2021

  1. Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour

    Redox Biology, Vol. 41

  2. Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke

    IUBMB Life, Vol. 73, Núm. 3, pp. 582-591

  3. Preconditioning‐activated akt controls neuronal tolerance to ischemia through the mdm2–p53 pathway

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2020

  1. Nuclear WRAP53 promotes neuronal survival and functional recovery after stroke

    Science advances, Vol. 6, Núm. 41

2019

  1. A novel human Cdh1 mutation impairs anaphase promoting complex/cyclosome activity resulting in microcephaly, psychomotor retardation, and epilepsy

    Journal of Neurochemistry, Vol. 151, Núm. 1, pp. 103-115

  2. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization

    Neuropharmacology, Vol. 146, pp. 19-27

  3. Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour

    Nature Metabolism

  4. Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice

    Scientific Reports, Vol. 9, Núm. 1

  5. The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism

    Translational Stroke Research, Vol. 10, Núm. 2, pp. 204-215

2018

  1. Hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function

    Redox Biology, Vol. 19, pp. 52-61

  2. Single-nucleotide polymorphism 309T>G in the MDM2 promoter determines functional outcome after stroke

    Stroke, Vol. 49, Núm. 10, pp. 2437-2444